Haemonetics provides timeline for CSL Plasma U.S. device rollout by year-end 2027

Haemonetics provided an update on its non-exclusive supply agreement with CSL Plasma, announcing that CSL expects to complete the rollout of Haemonetics' NexSys PCS® devices and disposables across all of its current U.S. plasma collection centers by the end of calendar year 2027. The company is not updating its fiscal 2027 guidance at this time.

Key Details

• Agreement Scope: CSL Plasma anticipates transitioning all of its current U.S. plasma collection centers to Haemonetics' NexSys PCS® devices with Persona® PLUS technology.
• Timeline: The nationwide rollout is expected to be completed by the end of calendar year 2027.
• Financial Impact: Haemonetics is not currently updating its fiscal 2027 guidance but plans to provide an update on the agreement's financial impact during its second-quarter earnings call in November 2026.